FREDRIC N ESHELMAN Insider Trading $MDCO MEDICINES CO /DE
Get free email notifications about insider trading for FREDRIC N ESHELMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of FREDRIC N ESHELMAN. FREDRIC N ESHELMAN is Director in Valeant Pharmaceuticals International, Inc. ($BVF) and CEO in PHARMACEUTICAL PRODUCT DEVELOPMENT INC ($PPDI) and Chief Executive Officer in PHARMACEUTICAL PRODUCT DEVELOPMENT INC ($PPDI) and Director in MEDICINES CO /DE ($MDCO) and Executive Chairman in MEDICINES CO /DE ($MDCO) and Director in Aravive, Inc. ($ARAV) and Director in G1 Therapeutics, Inc. ($GTHX) and Director in EYENOVIA, INC. ($EYEN).
FREDRIC N ESHELMAN in MEDICINES CO /DE
Trading Symbol: MDCOIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of FREDRIC N ESHELMAN: Executive Chairman, Director
Holdings: 1,132,149 shares
Current Value: $52,418,499
Latest Transaction: Jun 04 2018
$MDCO Market Capitalization: $3.32B
$MDCO Previous Close: $46.30
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of FREDRIC N ESHELMAN in MEDICINES CO /DE
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARAV, BVF, EYEN, GTHX, MDCO, PPDI
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 04 2018 | MDCO | MEDICINES CO /DE | ESHELMAN FREDRIC N | Executive Chairman | Option Exercise | A | 33.86 | 14,141 | 478,814 | 14,141 | |
Jun 04 2018 | MDCO | MEDICINES CO /DE | ESHELMAN FREDRIC N | Executive Chairman | Grant | A | 0.00 | 3,766 | 0 | 1,132,149 | 1.1 M to 1.1 M (+0.33 %) |
Dec 11 2017 | MDCO | MEDICINES CO /DE | ESHELMAN FREDRIC N | Executive Chairman | Buy | P | 26.65 | 100,000 | 2,665,000 | 1,128,383 | 1 M to 1.1 M (+9.72 %) |
Dec 11 2017 | MDCO | MEDICINES CO /DE | ESHELMAN FREDRIC N | Executive Chairman | Buy | P | 26.46 | 100,000 | 2,646,000 | 1,028,383 | 928.4 K to 1 M (+10.77 %) |
May 30 2017 | MDCO | MEDICINES CO /DE | ESHELMAN FREDRIC N | Director | Option Exercise | A | 39.39 | 13,577 | 534,798 | 13,577 | |
May 30 2017 | MDCO | MEDICINES CO /DE | ESHELMAN FREDRIC N | Director | Grant | A | 0.00 | 3,237 | 0 | 928,383 | 925.1 K to 928.4 K (+0.35 %) |
Dec 08 2016 | MDCO | MEDICINES CO /DE | ESHELMAN FREDRIC N | Director | Buy | P | 33.19 | 5,501 | 182,578 | 925,146 | 919.6 K to 925.1 K (+0.60 %) |
Dec 08 2016 | MDCO | MEDICINES CO /DE | ESHELMAN FREDRIC N | Director | Buy | P | 32.51 | 19,188 | 623,802 | 919,645 | 900.5 K to 919.6 K (+2.13 %) |
Dec 08 2016 | MDCO | MEDICINES CO /DE | ESHELMAN FREDRIC N | Director | Buy | P | 32.90 | 86,587 | 2,848,712 | 900,457 | 813.9 K to 900.5 K (+10.64 %) |
Dec 08 2016 | MDCO | MEDICINES CO /DE | ESHELMAN FREDRIC N | Director | Buy | P | 33.61 | 172,764 | 5,806,598 | 813,870 | 641.1 K to 813.9 K (+26.95 %) |
Dec 08 2016 | MDCO | MEDICINES CO /DE | ESHELMAN FREDRIC N | Director | Buy | P | 34.15 | 337,680 | 11,531,772 | 641,106 | 303.4 K to 641.1 K (+111.29 %) |
May 31 2016 | MDCO | MEDICINES CO /DE | ESHELMAN FREDRIC N | Director | Option Exercise | A | 37.22 | 14,700 | 547,134 | 14,700 | |
May 31 2016 | MDCO | MEDICINES CO /DE | ESHELMAN FREDRIC N | Director | Grant | A | 0.00 | 3,426 | 0 | 303,426 | 300 K to 303.4 K (+1.14 %) |
May 13 2016 | MDCO | MEDICINES CO /DE | ESHELMAN FREDRIC N | Director | Buy | P | 33.68 | 300,000 | 10,104,000 | 300,000 | 0 to 300 K |
Nov 25 2015 | MDCO | MEDICINES CO /DE | ESHELMAN FREDRIC N | Director | Option Exercise | P | 42.00 | 1,000 | 42,000 | 1,000 | |
Sep 01 2015 | MDCO | MEDICINES CO /DE | ESHELMAN FREDRIC N | Director | Option Exercise | A | 33.64 | 24,080 | 810,051 | 24,080 |
Page: 1